Annual Results Results Snapshot
Figures in Rs cr
Standalone - Balance Sheet Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2024 is -20.08% vs -20.64% in Mar 2023
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2024 is 0.24% vs 2.32% in Mar 2023
Investments
YoY Growth in year ended Mar 2024 is 0.00% vs -33.33% in Mar 2023
Current Assets
YoY Growth in year ended Mar 2024 is -1.47% vs 0.81% in Mar 2023
Compare Balance Sheet Results of Vista Pharma.
Figures in Rs cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
9.43
40.06
-30.63
-76.46%
Share Warrants & Outstandings
Total Reserve
26.22
9,560.50
-9,534.28
-99.73%
Shareholder's Funds
40.46
9,623.81
-9,583.35
-99.58%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
2.93
0.00
2.93
0.00%
Secured Loans
2.93
0.00
2.93
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-3.31
71.59
-74.90
-104.62%
Other Long Term Liabilities
0.00
17.16
-17.16
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.09
111.79
-111.70
-99.92%
Total Non-Current Liabilities
-0.28
200.54
-200.82
-100.14%
Current Liabilities
Trade Payables
7.41
849.52
-842.11
-99.13%
Other Current Liabilities
2.06
370.73
-368.67
-99.44%
Short Term Borrowings
5.03
0.00
5.03
0.00%
Short Term Provisions
0.00
373.11
-373.11
-100.00%
Total Current Liabilities
14.49
1,593.36
-1,578.87
-99.09%
Total Liabilities
54.67
11,417.71
-11,363.04
-99.52%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
27.06
4,271.87
-4,244.81
-99.37%
Less: Accumulated Depreciation
7.74
927.78
-920.04
-99.17%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
19.32
3,344.09
-3,324.77
-99.42%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
9.82
112.88
-103.06
-91.30%
Intangible assets under development
0.00
74.70
-74.70
-100.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.02
2,195.89
-2,195.87
-100.00%
Long Term Loans & Advances
2.12
137.64
-135.52
-98.46%
Other Non Current Assets
0.00
7.11
-7.11
-100.00%
Total Non-Current Assets
31.27
5,927.30
-5,896.03
-99.47%
Current Assets Loans & Advances
Current Investments
0.00
2,239.51
-2,239.51
-100.00%
Inventories
6.79
1,075.59
-1,068.80
-99.37%
Sundry Debtors
14.28
749.47
-735.19
-98.09%
Cash and Bank
0.09
761.01
-760.92
-99.99%
Other Current Assets
0.28
92.68
-92.40
-99.70%
Short Term Loans and Advances
1.95
572.15
-570.20
-99.66%
Total Current Assets
23.40
5,490.41
-5,467.01
-99.57%
Net Current Assets (Including Current Investments)
8.90
3,897.05
-3,888.15
-99.77%
Total Current Assets Excluding Current Investments
23.40
3,250.90
-3,227.50
-99.28%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
54.67
11,417.71
-11,363.04
-99.52%
Contingent Liabilities
0.00
261.93
-261.93
-100.00%
Total Debt
7.96
0.00
7.96
0.00%
Book Value per share (adjusted)
7.56
240.24
-232.68
-96.85%
Annual - Borrowings
Borrowings 7.96 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is -20.08% vs -20.64% in Mar 2023
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 29.14 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 0.24% vs 2.32% in Mar 2023
Annual - Investments
Investments 0.02 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 0.00% vs -33.33% in Mar 2023
Annual - Current Assets
Current Assets 23.40 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is -1.47% vs 0.81% in Mar 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
